Preparation of a powdery pharmaceutical composition by means of cryo-milling
First Claim
Patent Images
1. A method for preparing a powdery pharmaceutical composition comprising a pharmaceutical excipient and a pharmaceutical component, wherein the pharmaceutical excipient is polyethylene glycol having a molecular weight of up to 50,000 g/mol;
- the method comprising the steps of;
(a)(i) mixing the pharmaceutical excipient with the pharmaceutical component outside an extruder and then feeding the pharmaceutical excipient and the pharmaceutical component as mixed into the extruder;
or(ii) feeding the pharmaceutical excipient and the pharmaceutical component into the extruder at different feeding points, where either (1) the feeding point for the pharmaceutical excipient is located upstream with respect to the feeding point for the pharmaceutical component, or (2) the feeding point for the pharmaceutical component is located upstream with respect to the feeding point for the pharmaceutical excipient;
(b) extruding a mixture of the pharmaceutical excipient and the pharmaceutical component in the extruder at a temperature profile allowing a liquid melt of the mixture to congeal in the extruder and to exit the extruder in form of a powder extrudate; and
(c) grinding the powder extrudate at a temperature below ambient temperature, wherein the temperature below ambient temperature is at most −
10°
C.
1 Assignment
0 Petitions
Accused Products
Abstract
A method for the preparation of a powdery pharmaceutical composition composed of a pharmaceutical excipient and a pharmaceutical component, among other possible ingredients, wherein the pharmaceutical excipient is a polyalkylene glycol, the method involving grinding a mixture of the pharmaceutical excipient and the pharmaceutical component at a temperature below ambient temperature.
487 Citations
12 Claims
-
1. A method for preparing a powdery pharmaceutical composition comprising a pharmaceutical excipient and a pharmaceutical component, wherein the pharmaceutical excipient is polyethylene glycol having a molecular weight of up to 50,000 g/mol;
- the method comprising the steps of;
(a)(i) mixing the pharmaceutical excipient with the pharmaceutical component outside an extruder and then feeding the pharmaceutical excipient and the pharmaceutical component as mixed into the extruder; or (ii) feeding the pharmaceutical excipient and the pharmaceutical component into the extruder at different feeding points, where either (1) the feeding point for the pharmaceutical excipient is located upstream with respect to the feeding point for the pharmaceutical component, or (2) the feeding point for the pharmaceutical component is located upstream with respect to the feeding point for the pharmaceutical excipient; (b) extruding a mixture of the pharmaceutical excipient and the pharmaceutical component in the extruder at a temperature profile allowing a liquid melt of the mixture to congeal in the extruder and to exit the extruder in form of a powder extrudate; and (c) grinding the powder extrudate at a temperature below ambient temperature, wherein the temperature below ambient temperature is at most −
10°
C. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
- the method comprising the steps of;
Specification